CL Overzicht aandelen
Colgate-Palmolive Company produceert en verkoopt samen met haar dochterondernemingen consumentenproducten in de Verenigde Staten en internationaal. Meer informatie
Sneeuwvlok Score | |
---|---|
Waardering | 4/6 |
Toekomstige groei | 2/6 |
Prestaties in het verleden | 4/6 |
Financiële gezondheid | 4/6 |
Dividenden | 5/6 |
Beloningen
Risicoanalyse
Colgate-Palmolive Company Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | US$93.91 |
52 Week Hoogtepunt | US$109.30 |
52 Week Laag | US$75.50 |
Bèta | 0.41 |
11 maand verandering | -5.49% |
3 maanden verandering | -9.66% |
1 Jaar Verandering | 21.52% |
33 jaar verandering | 20.77% |
5 jaar verandering | 38.76% |
Verandering sinds IPO | 10,058.15% |
Recent nieuws en updates
Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price
Nov 20If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Recent updates
Colgate-Palmolive Company's (NYSE:CL) Intrinsic Value Is Potentially 63% Above Its Share Price
Nov 20If EPS Growth Is Important To You, Colgate-Palmolive (NYSE:CL) Presents An Opportunity
Oct 26Colgate-Palmolive Q3: Great Company, But Not Enough To Warrant A Position Now
Oct 25Colgate-Palmolive: Very Close To A Buy Following Recent Pullback
Oct 17Colgate-Palmolive: Share Price Returns Should Moderate (Rating Downgrade)
Sep 30These 4 Measures Indicate That Colgate-Palmolive (NYSE:CL) Is Using Debt Reasonably Well
Sep 11Returns At Colgate-Palmolive (NYSE:CL) Appear To Be Weighed Down
Aug 27Colgate-Palmolive: Stability Pillar Reached Its Fair Value
Aug 19An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 31% Undervalued
Aug 12Colgate-Palmolive: Good Growth Prospects Ahead
Aug 06Earnings Not Telling The Story For Colgate-Palmolive Company (NYSE:CL)
Jul 11Colgate-Palmolive: Three Items To Look For In The Upcoming Earnings
Jul 10Colgate-Palmolive: Gladly Holding, Yet Currently Not Buying An All Time Favorite
Jun 23Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Jun 06Many Would Be Envious Of Colgate-Palmolive's (NYSE:CL) Excellent Returns On Capital
May 21Analysts Have Made A Financial Statement On Colgate-Palmolive Company's (NYSE:CL) First-Quarter Report
Apr 30Colgate-Palmolive: Loading Up Ahead Of Earnings
Apr 16Why Investors Shouldn't Be Surprised By Colgate-Palmolive Company's (NYSE:CL) P/E
Apr 02Colgate-Palmolive's (NYSE:CL) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 18Is Colgate-Palmolive Company (NYSE:CL) Trading At A 33% Discount?
Feb 14Colgate-Palmolive: I'm Buying Before Interest Rates Decrease
Feb 14Colgate-Palmolive: Brushing Up Profits In Q4 2023
Jan 30Is Colgate-Palmolive (NYSE:CL) A Risky Investment?
Jan 19Getting In Cheap On Colgate-Palmolive Company (NYSE:CL) Might Be Difficult
Jan 01Colgate-Palmolive: A Better Year Ahead (Rating Upgrade)
Dec 20Colgate-Palmolive Stock And Its Real Value
Nov 29Brush Up With Colgate-Palmolive Stock As Earnings Growth Drips On
Nov 14Colgate-Palmolive (NYSE:CL) Will Want To Turn Around Its Return Trends
Nov 06Colgate-Palmolive: Own This Dividend King At The Right Price
Oct 31Why Colgate-Palmolive Is A Bargain You Shouldn't Ignore Right Now
Oct 13Does Colgate-Palmolive (NYSE:CL) Have A Healthy Balance Sheet?
Oct 02Colgate-Palmolive: Dividend King With Limited Growth
Sep 27An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 34% Undervalued
Sep 11Colgate-Palmolive: Improving Prospects And A Reasonable Valuation
Sep 09Colgate-Palmolive: A Healthy 7% Return With A Safe Dividend For Investors In A Post-Pandemic World
Aug 16Colgate And The Importance Of Sales Growth, Expectations Matter
Aug 09Colgate-Palmolive's (NYSE:CL) Returns On Capital Not Reflecting Well On The Business
Aug 03Colgate-Palmolive: Challenging Growth Prospects
Jul 10Colgate-Palmolive (NYSE:CL) Is Increasing Its Dividend To $0.48
Jun 27Colgate-Palmolive (NYSE:CL) Will Pay A Larger Dividend Than Last Year At $0.48
Jun 13Colgate-Palmolive: The Reasons We Are Becoming More Cautious
Jun 05Rendement voor aandeelhouders
CL | US Household Products | US Markt | |
---|---|---|---|
7D | 3.1% | 2.6% | -1.0% |
1Y | 21.5% | 13.2% | 30.3% |
Rendement versus industrie: CL overtrof de US Household Products industrie, die het afgelopen jaar een rendement 13.2 % opleverde.
Rendement versus markt: CL presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.3 % opleverde.
Prijsvolatiliteit
CL volatility | |
---|---|
CL Average Weekly Movement | 2.5% |
Household Products Industry Average Movement | 3.0% |
Market Average Movement | 6.2% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: CL heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van CL is het afgelopen jaar stabiel geweest.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1806 | 34,000 | Noel Wallace | www.colgatepalmolive.com |
Colgate-Palmolive Company produceert en verkoopt samen met haar dochterondernemingen consumentenproducten in de Verenigde Staten en internationaal. Het bedrijf is actief in twee segmenten: Mondverzorging, Persoonlijke Verzorging en Huishoudelijke Verzorging; en Huisdierenvoeding. Het segment Mondverzorging, Persoonlijke Verzorging en Huishoudelijke Verzorging biedt tandpasta, tandenborstels, mondwater, handzeep, douchegels, shampoos, conditioners, deodorants en antitranspiratiemiddelen, huidverzorgingsproducten, vaatwasmiddelen, wasverzachters, huishoudelijke reinigingsmiddelen en andere gerelateerde producten.
Colgate-Palmolive Company Samenvatting
CL fundamentele statistieken | |
---|---|
Marktkapitalisatie | US$76.48b |
Inkomsten(TTM) | US$2.87b |
Inkomsten(TTM) | US$20.11b |
26.8x
Koers/Winstverhouding3.8x
P/S-verhoudingIs CL overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
CL resultatenrekening (TTM) | |
---|---|
Inkomsten | US$20.11b |
Kosten van inkomsten | US$7.96b |
Brutowinst | US$12.15b |
Overige uitgaven | US$9.28b |
Inkomsten | US$2.87b |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | 3.51 |
Brutomarge | 60.42% |
Nettowinstmarge | 14.26% |
Schuld/Eigen Vermogen Verhouding | 1,009.1% |
Hoe presteerde CL op de lange termijn?
Bekijk historische prestaties en vergelijking